Insider Transactions in Q2 2022 at Allscripts Healthcare Solutions, Inc. (MDRX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
Elizabeth Ann Altman |
BUY
Grant, award, or other acquisition
|
Direct |
12,756
+26.41%
|
-
|
|
Jun 27
2022
|
Greg Garrison Execuitive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
12,756
+17.4%
|
-
|
|
Jun 27
2022
|
Jonathan Judge |
BUY
Grant, award, or other acquisition
|
Direct |
12,756
+8.78%
|
-
|
|
Jun 27
2022
|
David B Stevens |
BUY
Grant, award, or other acquisition
|
Direct |
12,756
+14.45%
|
-
|
|
Jun 27
2022
|
Carol J Zierhoffer |
BUY
Grant, award, or other acquisition
|
Direct |
12,756
+23.18%
|
-
|
|
Jun 10
2022
|
Paul Black Director |
SELL
Open market or private sale
|
Direct |
60,000
-4.56%
|
$960,000
$16.58 P/Share
|
|
Jun 07
2022
|
Paul Black Director |
SELL
Open market or private sale
|
Direct |
75,000
-5.4%
|
$1,275,000
$17.35 P/Share
|
|
Jun 06
2022
|
Paul Black Director |
SELL
Open market or private sale
|
Direct |
65,450
-4.5%
|
$1,112,650
$17.3 P/Share
|
|
Jun 03
2022
|
Paul Black Director |
SELL
Open market or private sale
|
Direct |
75,000
-4.9%
|
$1,275,000
$17.33 P/Share
|
|
May 27
2022
|
David B Stevens |
SELL
Open market or private sale
|
Direct |
47,347
-43.0%
|
$757,552
$16.85 P/Share
|
|
May 27
2022
|
Elizabeth Ann Altman |
SELL
Open market or private sale
|
Direct |
6,028
-20.91%
|
$96,448
$16.75 P/Share
|
|
May 25
2022
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,552
-3.49%
|
$26,384
$17.3 P/Share
|
|
May 17
2022
|
Paul Black Director |
SELL
Open market or private sale
|
Direct |
50,000
-3.17%
|
$900,000
$18.18 P/Share
|
|
May 17
2022
|
Richard J. Poulton CEO |
SELL
Open market or private sale
|
Direct |
10,000
-1.31%
|
$170,000
$17.86 P/Share
|
|
May 16
2022
|
Richard J. Poulton CEO |
SELL
Open market or private sale
|
Direct |
10,000
-1.3%
|
$170,000
$17.94 P/Share
|
|
May 13
2022
|
Paul Black Director |
SELL
Open market or private sale
|
Direct |
50,000
-3.07%
|
$900,000
$18.01 P/Share
|
|
May 10
2022
|
Tejal Vakharia SVP General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
32,450
+11.43%
|
-
|
|
May 10
2022
|
Richard J. Poulton CEO |
BUY
Grant, award, or other acquisition
|
Direct |
135,209
+14.91%
|
-
|
|
May 10
2022
|
Thomas Langan CEO |
SELL
Open market or private sale
|
Direct |
51,537
-26.92%
|
$927,666
$18.12 P/Share
|
|
May 10
2022
|
Lisa Hammond SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,634
+32.7%
|
-
|
|
May 01
2022
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,301
-1.93%
|
$86,020
$20.66 P/Share
|
|
Apr 02
2022
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,841
-0.82%
|
$42,343
$23.09 P/Share
|
|
Apr 01
2022
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,391
-1.05%
|
$54,993
$23.09 P/Share
|